World Journal of Endocrine Surgery

Register      Login

VOLUME 4 , ISSUE 2 ( May-August, 2012 ) > List of Articles

CASE REPORT

Quadruple Metachronous Malignancy in a Single Patient with Multiple Sclerosis

Yasuhiro Ito, Marko Buta, Ziv Radisavljevic, Zorka Milovanovic, Dragana Lavrnic, Igor Djurisic, Merima Oruci, Gordana Pupic, Radan Dzodic

Citation Information : Ito Y, Buta M, Radisavljevic Z, Milovanovic Z, Lavrnic D, Djurisic I, Oruci M, Pupic G, Dzodic R. Quadruple Metachronous Malignancy in a Single Patient with Multiple Sclerosis. World J Endoc Surg 2012; 4 (2):79-82.

DOI: 10.5005/jp-journals-10002-1102

Published Online: 01-08-2012

Copyright Statement:  Copyright © 2012; The Author(s).


Abstract

How to cite this article

Buta M, Ito Y, Radisavljevic Z, Milovanovic Z, Lavrnic D, Djurisic I, Oruci M, Pupic G, Dzodic R. Quadruple Metachronous Malignancy in a Single Patient with Multiple Sclerosis. World J Endoc Surg 2012;4(2):79-82.


PDF Share
  1. Quadruple primary malignancies of liver, bladder, lung and stomach in one patient. Tumori 2010;96:787-91.
  2. Multiple primary malignancies including colon, stomach, lung, breast and liver cancer: A case report and literature review. Chin Med J (Engl) 2009;122:3091-93.
  3. Rating neurologic impairment in multiple sclerosis. An expanded disability status scale (EDSS). Neurology 1983;33:1444.
  4. Quadruple cancer, including triple cancers in the head and neck region. Neoplasma 2002;49:412-14.
  5. A case of quadruple primary malignancies including breast, tongue and thyroid cancers and osteosarcoma in a young female without karyotype abnormality. Breast Cancer 2011 May 12. [Epub ahead of print], available at http://www.springerlink.com.proxy.kobson.nb.rs :2048/content/1340-6868/?MUD=MPandk=tongue.
  6. A surgical case of quadruple lung cancer. Ann Thorac Cardiovasc Surg 2010;16:345-50.
  7. Quadruple malignancy in a single patient: A case report and comprehensive review of literature. J Cancer Res Ther 2010;6:230-32.
  8. A case report of quadruple cancer in a single patient including the breast, rectum, ovary and endometrium. J Gynecol Oncol 2008;19:265-69.
  9. A case of quadruple cancer including urinary bladder, oral cavity, stomach and lung. Hinyokika Kiyo 2004;50:429-33.
  10. The branchial and pharyngeal apparatus. The integumentary system. In: The developing human: Clinically oriented embryology, (5th edn). Philadelphia: WB Saunders Company 1993;186-223, 443-50.
  11. Risk of acute promyelocytic leukemia in multiple sclerosis: Coding variants of DNA repair genes. Neurology 2011;76:1059-65.
  12. Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2010;74:1463-70.
  13. Long-term risk of leukaemia or cardiomyopathy after mitoxantrone therapy for multiple sclerosis. Eur Neurol 2011;67:45-47.
  14. High incidence of synchronous or metachronous breast cancer in patients with malignant and bening thyroid tumor or tumor-like disorders. Anticancer Research 2009;29:1607-10.
  15. Sentinel lymph node biopsy may be used to support the decision to perform modified radical neck dissection in differentiated thyroid carcinoma. World J Surg 2006;30:841-46.
  16. Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells. J Cell Biochem 2004;92:511-15.
  17. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-46.
  18. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
  19. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-22.
  20. BRCA1 and BRCA2 mutations and breast cancer. Discov Med 2011;12:445-53.
  21. Screening for wellcharacterized paraneoplastic antineuronal antibodies in multiple sclerosis. Int J Neurosci 2011;121:477-79.
  22. Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3a)/ROCK kinase pathway in human breast carcinoma cells. Cancer 2003;97:1358-63.
  23. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem 2000;275:20770-74.
  24. Locus of fragility in robust breast cancer system. J Cell Biochem 2004;92:711-15.
  25. AKT as locus of fragility in robust cancer system. J Cell Biochem 2008;104:2071-77.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.